Successful 10-year outcomes after supracricoid partial laryngectomy for selected glottic squamous cell carcinoma classified as T3N0M0: A STROBE analysis

被引:0
|
作者
Laccourreye, O. [1 ]
Chambrin, G. [1 ]
Garcia, D. [2 ]
Troux, C. [1 ]
Mirghani, H. [1 ]
Giraud, P. [3 ]
机构
[1] Univ Paris Cite, HEGP, AP HP, Serv Otorhino Laryngol & Chirurg Cerv Faciale, 20-40, Rue Leblanc, F-75015 Paris, France
[2] Hop Francais, SO1 Pho Phuong Mai, Hanoi, Vietnam
[3] Univ Paris Cite, Serv Oncol Radiotherapie, HEGP, AP HP, 20-40 Rue Leblanc, F-75015 Paris, France
关键词
Cancer; Larynx; Glottis; Laryngeal preservation; Supracricoid partial laryngectomy; VOCAL CORD; SURVIVAL OUTCOMES; CRICOHYOIDOEPIGLOTTOPEXY; CHEMOTHERAPY; CANCER; PRESERVATION; STATISTICS; SOCIETY; HEAD;
D O I
10.1016/j.anorl.2022.12.006
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Purpose: To evaluate long-term oncological outcome for patients with selected glottic squamous cell carcinoma (SCC) classified as T3N0M0 treated by supracricoid partial laryngectomy (SCPL). Materials and methods: Analysis of an inception cohort of 46 patients with isolated untreated SCC classified as T3N0M0 and minimum 10-year follow-up, consecutively treated by SCPL between 1982 and 2012 in a French university teaching hospital. The main endpoint was 5- and 10-year actuarial survival and local control estimates. Accessory endpoints comprised cause of death, screening for variables decreasing survival and increasing risk of local recurrence, oncologic consequences of local recurrence, and laryngeal preservation rate. Results: Five- and 10-year actuarial survival was 78.1%, and 53.3%, respectively. The main causes of death were intercurrent disease and metachronous second primary, each in 33.3% of cases. Postoperative mortality (aspiration pneumonia) was 2.1%. There were no significant correlations between survival and any study variables. Five- and 10-year local control was 90.5%. Overall local recurrence varied significantly (P = 0.003), from 2.3% with negative margins (R0) to 100% with positive margins (R1) and/or dysplasia. Local recurrence was associated with a significantly (P < 0.005) increased risk of nodal failure and distant metastasis, and reduced survival. Overall laryngeal preservation was 89.1%. Conclusion: The present results suggest that SCPL should continue to be taught and that this type of partial laryngeal surgery should be included in the various organ-sparing strategies considered in advanced laryngeal cancer. (c) 2022 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:165 / 170
页数:6
相关论文
共 50 条
  • [41] Factors on prognosis in patients of stage pT3N0M0 thoracic esophageal squamous cell carcinoma after two-field esophagectomy
    Wang, Yuxiang
    Wang, Lili
    Yang, Qiong
    Li, Jing
    Qi, Zhan
    He, Ming
    Yao, Jifang
    Qiao, Xueying
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (05) : C16 - C23
  • [42] Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation
    Furusaka, Tohru
    Susaki, Yasuhiko
    Saito, Tsutomu
    Katsura, Yoshihisa
    Ikeda, Minoru
    ACTA OTO-LARYNGOLOGICA, 2013, 133 (01) : 91 - 98
  • [43] Radiotherapy Versus Surgery-Which Is Better for Patients With T1-2N0M0 Glottic Laryngeal Squamous Cell Carcinoma? Individualized Survival Prediction Based on Web-Based Nomograms
    Du, Yajing
    Shao, Shali
    Lv, Minghe
    Zhu, Yi
    Yan, Li
    Qiao, Tiankui
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [44] Patterns of Lymph Node Recurrence after Radical Surgery Impacting on Survival of Patients with pT1-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma
    Chen, Xiao-li
    Chen, Tian-wu
    Fang, Zhi-jia
    Zhang, Xiao-ming
    Li, Zhen-lin
    Li, Hang
    Tang, Hong-jie
    Zhou, Li
    Wang, Dan
    Zhang, Zishu
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2014, 29 (02) : 217 - 223
  • [45] Analysis of local recurrence in patients with selected T1-3N0M0 squamous cell carcinoma of the true vocal cord managed with a platinum-based chemotherapy-alone regimen for cure
    Laccourreye, O
    Veivers, D
    Bassot, V
    Ménard, M
    Brasnu, D
    Laccourreye, H
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 2002, 111 (04) : 315 - 321
  • [46] Comparison of Outcomes Between Additional Esophagectomy After Noncurative Endoscopic Resection and Upfront Esophagectomy for T1N0 Esophageal Squamous Cell Carcinoma
    Maruyama, Suguru
    Okamura, Akihiko
    Imamura, Yu
    Kanamori, Jun
    Kanie, Yasukazu
    Takahashi, Keita
    Fujiwara, Daisuke
    Watanabe, Masayuki
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (09) : 4859 - 4866
  • [47] Author's Reply: Comparison of Outcomes Between Additional Esophagectomy After Noncurative Endoscopic Resection and Upfront Esophagectomy for T1N0 Esophageal Squamous Cell Carcinoma
    Maruyama, Suguru
    Okamura, Akihiko
    Watanabe, Masayuki
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (SUPPL 3) : 839 - 840
  • [48] Endoscopic-assisted selective neck dissection via small lateral neck incision for early-stage (T1-2N0M0) head and neck squamous cell carcinoma: 3-year follow-up results
    Liang, Faya
    Fan, Song
    Han, Ping
    Cai, Qian
    Lin, Peiliang
    Chen, Renhui
    Yu, Shitong
    Huang, Xiaoming
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2017, 31 (02): : 894 - 900
  • [49] Pattern of recurrence and prognostic factors in patients with pT1-3N0 esophageal squamous cell carcinoma after surgery: analysis of a single center experience
    Lin, Gang
    Liu, Haibo
    Li, Jian
    JOURNAL OF CARDIOTHORACIC SURGERY, 2019, 14 (1)
  • [50] Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma
    Kadota, Tomohiro
    Sato, Daiki
    Inaba, Atsushi
    Nishihara, Keiichiro
    Takashima, Kenji
    Nakajo, Keiichiro
    Yukami, Hiroki
    Mishima, Saori
    Sawada, Kentaro
    Kotani, Daisuke
    Fujiwara, Hisashi
    Nakamura, Masaki
    Hojo, Hidehiro
    Yoda, Yusuke
    Kojima, Takashi
    Fujita, Takeo
    Yano, Tomonori
    ESOPHAGUS, 2022, 19 (01) : 153 - 162